다우존스 지수

실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

등록

홈
인베스팅
주식
영국
LSE
Gt Biopharma Inc (0RU9)
Gt Biopharma Inc (0RU9) 뉴스

0RU9

Gt Biopharma (0RU9)

Gt Biopharma Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:LSE:0RU9

1

일자	시간	출처	헤드라인	심볼	기업
2019/09/12	20:30	PR Newswire (US)	GT Biopharma Announces FDA Notification of Commencement of Enrollment in Human GTB-3550 Trike™ Phase i/ii Clinical Trial	LSE:0RU9	Gt Biopharma Inc
2019/09/12	20:30	PR Newswire (US)	GT Biopharma Announces FDA Notification of Commencement of Enrollment in Human GTB-3550 Trike™ Phase i/ii Clinical Trial	LSE:0RU9	Gt Biopharma Inc
2019/06/13	20:30	PR Newswire (US)	GT Biopharma GTB-1550	LSE:0RU9	Gt Biopharma Inc
2019/06/13	20:30	PR Newswire (US)	GT Biopharma GTB-1550	LSE:0RU9	Gt Biopharma Inc
2019/05/29	20:30	PR Newswire (US)	GT Biopharma GTB-1550 PHASE I-II Results to be Published in Conjunction With 2019 ASCO Meeting May 31 - June 4 in Chicago	LSE:0RU9	Gt Biopharma Inc
2019/05/29	20:30	PR Newswire (US)	GT Biopharma GTB-1550 PHASE I-II Results to be Published in Conjunction With 2019 ASCO Meeting May 31 - June 4 in Chicago	LSE:0RU9	Gt Biopharma Inc
2019/03/26	20:30	PR Newswire (US)	GT Biopharma Announces Completion of Management Restructuring	LSE:0RU9	Gt Biopharma Inc
2018/08/30	21:00	PR Newswire (US)	GT Biopharma's Chairman and Chief Executive Officer Raymond W Urbanski, M.D., Ph.D Provides Insight Into the Impact of the Re...	LSE:0RU9	Gt Biopharma Inc
2018/08/29	20:45	PR Newswire (US)	GT Biopharma's Chairman and Chief Executive Officer Provides Insight Into the Impact of the Recent Affimed/Roche-Genetech Col...	LSE:0RU9	Gt Biopharma Inc
2018/08/24	21:00	PR Newswire (US)	GT Biopharma Announces the Appointment of David Cardino, CPA, MBA as Vice President of Finance	LSE:0RU9	Gt Biopharma Inc
2018/08/14	21:00	PR Newswire (US)	GT Biopharma Announces GTBP CEO, Dr. Raymond Urbanski, to Make Presentation at the 2018 Wedbush PacGrow Healthcare Conference	LSE:0RU9	Gt Biopharma Inc
2018/07/25	21:00	PR Newswire (US)	GT Biopharma Announces the Addition of Dr. John N. Bonfiglio to its Board of Directors	LSE:0RU9	Gt Biopharma Inc
2018/07/19	21:00	PR Newswire (US)	GT Biopharma Inc. Announces Agreement with a Major Pharmaceutical Company to Study its Drug Candidate OXS-1550 in Combination...	LSE:0RU9	Gt Biopharma Inc
2018/06/05	21:00	PR Newswire (US)	GT Biopharma Announces Voluntary Lock-Up Agreements With Insiders Covering Over 52% of Outstanding Shares	LSE:0RU9	Gt Biopharma Inc
2018/05/14	20:45	PR Newswire (US)	Gt Biopharma Announces Dr. Raymond W Urbanski Elevated to President and Chief Medical Officer of the Company	LSE:0RU9	Gt Biopharma Inc
2018/04/26	21:30	PR Newswire (US)	Seasoned Financial Executive Federica O'Brien Joins GT Biopharma's Board of Directors	LSE:0RU9	Gt Biopharma Inc
2018/04/24	22:15	PR Newswire (US)	Former Sucampo Chief Scientific Officer, Dr. Peter Kiener, Joins GT Biopharma's Board of Directors	LSE:0RU9	Gt Biopharma Inc
2018/03/29	22:05	PR Newswire (US)	GT Biopharma Inc. Announces >50% Enrollment in Proof-Of-Concept Clinical Trial For Its Novel Treatment For Motion Sickness	LSE:0RU9	Gt Biopharma Inc
2018/02/13	21:45	PR Newswire (US)	GT Biopharma Announces Dr. Jeffrey Miller, Renowned NK Cell Cancer Specialist, Will Present at Cell Therapy Symposia	LSE:0RU9	Gt Biopharma Inc
2018/01/24	22:39	PR Newswire (US)	GT Biopharma, Inc. Issues Letter to Shareholders	LSE:0RU9	Gt Biopharma Inc
2017/12/19	00:27	PR Newswire (US)	GT Biopharma, Inc. Files Application for NASDAQ Capital Market Listing	LSE:0RU9	Gt Biopharma Inc

검색 관련기사 보기:LSE:0RU9

1

US Dollar vs Yen

Financial Select Sector

Gold vs US Dollar

Energy Select Sector SPDR

Invesco QQQ Trust Series 1

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관